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Summary. The effects of systemic administration f dizocilpine (0.16 mg/kg, 
i.p.), clozapine (7.5 mg/kg, s.c.) and coadministration f dizocilpine (0.16rag/ 
kg, i.p.) and clozapine (7.5 mg/kg, s.c.) on acquisition of delayed alternation i
a T-maze were tested in rats (N = 7 per group) on six days with 10 choices per 
day and animal. Clozapine given alone did not impair delayed alternation 
learnint, except of the first day. Dizocilpine induced a significant delayed al- 
ternation impairment on all days tested. Pretreatment with clozapine signifi- 
cantly improved the dizocilpine-induced impairment. Treatment-induced 
changes of delayed alternation learning and of locomotor activities howed no 
correlation. The results demonstrate hat clozapine functionally compensated 
for deficits induced by a blockade of the N-methyl-D-asparatate (NMDA) 
subtype of glutamate r ceptors. 
Keywords: Clozapine, dizocilpine, glutamate, NMDA receptors, delayed alter- 
nation, locomotion, schizophrenia 
Introduction 
The glutamate hypothesis of schizophrenia proposed by Kim et al. (1980) and 
Kornhuber and Kornhuber (1986) postulates that a decreased glutamate trans- 
mission is involved in the pathophysiology of this disease. In line with this 
hypothesis are findings that antagonists ofthe N-methyl-D-aspartate (NMDA) 
subtype of glutamate receptors as phencyclidine (PCP) or dizocilpine induce 
psychotic reactions in humans resembling those seen in schizophrenia (Allen 
and Young, 1978; Troupin et al., 1986). Furthermore intake of PCP exacerbate 
a preexisting psychosis (Luby etal., 1959). Hence, PCP-induced psychosis is 
regarded to be the best pharmacological model of schizophrenia (Allen and 
Young, 1978) representing positive as well as negative symptoms (Petersen and 
Stillman, 1978). The glutamate hypothesis of schizophrenia was further cor- 
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roborated by observations that parkinsonian patients treated with the anti- 
parkinson drugs amantadine or memantine which both are noncompetitive 
NMDA antagonists can develop psychotic side effects (Riederer et al., 1992). 
In postmortem tissue of patients with schizophrenia, NMDA receptor densities 
are increased in temporal and parietal cortical areas (Suga et al., 1990) and the 
putamen (Kornhuber et al., 1989) and glutamate-release i  reduced in frontal 
and temporal cortical tissue (Sherman etal., 1991). In addition, NMDA-as- 
sociated glycine binding sites are increased in schizophrenic brains (Ishimaru 
et al., 1992). These findings tentatively support the view of a decreased gluta- 
matergic function and receptor upregulation i  schizophrenia. 
In rodents NMDA antagonists induce a strong behavioural ctivation char- 
acterized by an increased locomotion, stereotypy (Clineschmidt etal., 1982; 
Tiedtke etal., 1990; Hoffman, 1992), turning in the Ungerstedt model (Cli- 
neschmidt et al., 1982) and cognitive impairments leading to a deficient delayed 
alternation learning (Schmidt etal., 1988; Hauber and Schmidt, 1990). In ad- 
dition, prepulse inhibition of the startle response isimpaired in rats with systemic 
injections of dizocilpine or PCP. Prepulse inhibition is also decreased in schizo- 
phrenic patients (Mansbach and Geyer, 1989). The behavioural syndrome 
induced by NMDA antagonists resembles in many respects the behavioural 
activiation induced by dopamine agonists. However, the psychomotor activation 
due to blockade of NMDA receptors is still present in animals pretreated with 
a-methyl-paratyrosine a d reserpine as shown by Carlsson and Carlsson (1989). 
There is growing evidence for interactions between glutamatergic and do- 
paminergic systems in the basal ganglia which may be relevant for the symp- 
tomatology and the treatment of schizophrenia (see Carlsson and Carlsson, 
1990; Schmidt et al., 1992 for review). Intracerebral injection of kynurenic acid, 
an unselective glutamate antagonist, or AP-5, a competitive NMDA antagonist, 
into the dorsal striatum induced locomotion and sniffing (Schmidt, 1985, 1986). 
Local infusion of dizocilpine or SDZ EAA 494 into the dorsal striatum also 
enhanced sniffing and locomotion (Imperato et al., 1990). Inactivation of striatal 
neurons bearing NMDA receptors with the excitotoxin quinolinic acid produced 
a similar behavioural activation (Sanberg et al., 1989; Schmidt et al., 1988). In 
addition, intrastriatal infusion of AP-5 antagonized neuroleptic-induced cata- 
lepsy (Yoshida et al., 1991) and in turn, intrastriatal infusion of NMDA reduced 
behavioural activities (Schmidt and Bury, 1988). Accordingly, systemically ap- 
plied NMDA was found to potentiate haloperidol-catalepsy (Mehta and Ticku, 
1990). 
Clozapine is an atypical antipsychotic drug and the mechanism of action 
of this compound is largely unknown. Recent studies showed that clozapine 
antagonized izocilpine-induced stereotypy (Tiedtke etal., 1990; Hoffman, 
1992). Furthermore, stereotypy induced by intrastriatal injection of AP-5 was 
antagonized by systemic administration of clozapine (Schmidt, 1986). On the 
basis of the glutamate hypothesis of schizophrenia it was concluded that clo- 
zapine may act as a functional glutamate agonist via the NMDA receptor 
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(Schmidt, 1986, 1991). Interestingly, NMDA was found to share ctozapine-like 
dicrimminative stimulus effects in rats (Schmidt and Volz, 1992). 
In the present study we investigated possible glutamate-mimetic effects of 
clozapine. We examined the effects of dizocilpine and clozapine on delayed 
alternation learning of rats in a T-maze, because 
I) psychomotor stimulation due to blockade of NMDA receptors may be 
a model of psychosis and 
II) the delayed alternation procedure is a sensitive task on integrity of the 
dorsal striatum (Wikmark et al., 1973) and the prefrontal cortex as well (Fuster, 
1981; Markowitsch and Pritzel, 1977). Since pathophysiology of schizophrenia 
may be related to a frontostriatal dyfunction (see Robbins, 1990 for review) 
and cortico-striatal glutamatergic neurons are involved in regulation of psy- 
chomotor  functions (Carlsson and Carlsson, 1989), this task may be especially 
appropriate. 
In our experiments we tested the effects of systemically administered di- 
zocilpine or clozapine and the effect of clozapine in dizocilpine-pretreated an-
imals. Dizocilpine was used in a dose of 0.16 mg/kg which is known to produce 
a significant impairment in this task (Schmidt et al., 1988). In order to assess 
a possible effect of treatment-induced locomotor changes on learning data we 
measured the running times as an index of locomotor activity from all runs in 
the maze. 
If clozapine act as a functional glutamate agonist via NMDA receptors I) it 
should counteract he impairment in dizocilpine-pretreated animals and 
II) when given alone it should at least theoretically even improve learning. 
Materials and methods 
Subjects 
Subjects used in this experiment were 28 male Sprague-Dawley rats weighing 250-300 g
(Interfauna, Tuttlingen, FRG). Rats were housed in groups of four or five per cage and 
had free access to water. They received 12 g standard laboratory maintenance diet (Altromin, 
Lage, FRG) per day and animal. All rats were housed in a colony room maintained at 
22 4- 3 ~ on a 12:12 hours light-dark cycle (lights on 06.00h). 
Apparatus 
Delayed alternation was conducted in a T-maze which was made of plastic coated wood 
with 35 cm high walls and 20 cm wide corridors. The stem was divided by an opaque and 
manually operated guillotine door into a startbox (length: 30 cm) and a runway (length: 
60 cm). At the end of both other arms (length: 70 cm) a food cup was located. 
Behavioural procedure 
The procedure was designed with reference to the description of Wikmark et al. (1973). 
Adaption: The animals were adapted to the maze on four days. On the first day, animals 
were left into the maze in groups of four and five for 10min. The next day, food cups in 
both arms were baited with food pellets (45 mg; Noyes, Lancaster, U.K.), the guillotine 
door was removed and each rat was left in the maze for 5 rain. On day three of adaption, 
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the guillotine door was introduced and an animal was repeadetly placed into the start box 
and the door was raised immediatly afterwards. The rats were trained to respond to the 
opening of the door and to enter one of the arms. 
Delayed alternation." Four randomized groups (N -- 7 per group) were used receiving 
injections with either saline, clozapine, dizocilpine or clozapine plus dizocilpine. After the 
injection a rat was placed back into the home cage for 30 min. Thereafter a rat was tested 
in one session per day comprising 11 choices. Maze learning was tested on six days. On 
the initial choice (not scored) both arms were baited. On each of the following choices the 
animal was rewarded with one food pellet for entering the arm not visited on the previous 
run, i.e. an arm was baited until the rat responded to it. Errors were defined as successive 
choices of the same arm and were scored by video observation. The criterion for a scored 
arm entry was a complete ntry in an arm with all four paws. In addition the time from 
raising the guillotine door up to an animals arrival at the food cup was measured from 
each choice and was termed here as running time. 
Drugs 
Dizocilpine ([ + ]- 5-methyl- 10,11 -dihydro- 5 H-dibenzo(a,d)cyclohepten- 5,10 imine) (Bio- 
trend, K61n, FRG) was dissolved in physiological saline and administered intraperitoneally. 
Clozapine (8-chloro-ll-(4-methyl-l-piperazinyl)-5H-dibenzo[b,e]-[1,4]diazepine) (San- 
doz) was dissolved in sesame oil and administered subcutaneously in the neck region. The 
behavioural procedure was initiated 30rain after injection of either saline (1 ml/kg, i.p.), 
dizocilpine (0.16 mg/kg, i.p.), clozapine (7.5 mg/kg, s.c.) or coadministration f clozapine 
and dizocilpine at the given doses. 
Data analysis 
The data were submitted to an analysis of variance (ANOVA) followed by an appropriate 
post hoc test for multiple comparisons of means or a T-test. For error data, a two-way 
ANOVA with days and treatment groups as factors was calculated followed by a Tukey- 
test. The running time data were submitted to a one-way ANOVA followed by a Tukey- 
test for multiple comparisons. For simple comparisons a T-test was used. Differences were 
considered to be significant if the p-value is less then 0.05. 
Results 
A two-way ANOVA with treatment groups and days as factors revealed a 
significant effect of treatment F(3, 126) = 71.1, p < 0.0001, a significant effect 
of  days F(5, 41) = 6.25, p ~< 0.0003 as well as a significant interaction between 
days and groups F(15, 108) = 2.32, p < 0.0065. A post hoc Tukey-test showed 
that dizocilpine-treatment produced on each day a significant increase of errors 
as compared to saline controls (p < 0.01 for each day). Clozapine-treated an- 
imals made, except of  the first day (p < 0.05), not more errors than saline- 
treated animals. Animals with injections of clozapine plus dizocilpine were, 
except of the first day (p < 0.01), not different from saline-treated animals. A 
comparison of  dizocilpine- and dizocilpine plus clozapine-treatment revealed, 
that both groups were not different on the first two days, but from the third 
day on, dizocilpine plus clozapine-treated animals made significantly less errors 
than dizocilpine-treated animals (Fig. 1). The mean running times from all days 
were shown for each treatment group in Fig. 2. A one-way ANOVA with 
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Fig. 1. Mean errors (4- SEM) of groups (N = 7 for each group) treated with saline (1 ml/ 
kg, i.p.), clozapine (7.5 mg/kg., s.c.), dizocilpine (0.16 mg/kg, i.p.) and coadministration f 
clozapine and dizocilpine (at the given doses) tested for six days on acquisition of a delayed 
alternation task in a T-maze. A: dizocitpine treatment versus aline treatment (aa: p < 0.01); 
b: clozapine treatment versus aline treatment (b: p < 0.05); c: dizocilpine plus clozapine 
treatment versus aline treatment (cc: p < 0.01); d: dizocilpine treatment versus dizocilpine 
plus clozapine treatment (d: p < 0.05, dd: p < 0.01)(ANOVA followed by Tukey's test) 
treatment as factor revealed a significant effect F(3, 1679) = 60.59, p < 0.0001. 
A post hoc Tukey-test showed that clozapine-treated animals were signiticantly 
slower (p < 0.01), dizocilpine-and izocilpine plus clozapine-treated animals 
significantly faster than saline treated animals (p < 0.01 and p < 0.05). In ad- 
dition, dizocilpine coadministration significantly antagonized the clozapine- 
induced slowing (p < 0.01). 
In order to reveal a possible relationship between running time and errors 
we compared the mean running times of all dizocilpine-treated rats from correct 
and incorrect choices of all days and found no significant differences, 
t(417) = - 0.44; p = 0.97 (T-test) (Fig. 3). Since this within-group comparison 
may be confounded by different individual speed preferences of the animals 
and other factors, we compared the mean running times from each dizocilpine- 
treated animal in correct and incorrect choices from all days: In none of the 
dizocilpine-treated animals a significant difference of running times in correct 
and incorrect choices was found (not shown). We further investigated whether 
errors in ten choices from each day and animal are a function of the corre- 
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Fig. 2. Mean running times (4- SEM) for each treatment group (N = 7, n = 420 for each 
group) pooled from all days tested. * p < 0.05; ** p < 0.01 ANOVA followed by Tukey's 
t-test 
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Fig. 3. Mean running times (4- SEM) of dizocilpine-treated animals (N = 7) in correct 
(n -- 180) and incorrect (n -- 240) choices pooled from all days (p = 0.97, t-test) 
sponding mean running times. An analysis comprising the data from all groups 
with running time as independent and errors as dependent variable revealed no 
correlation (r = 0.0154). Within-group analysis also revealed no correlations of 
individual errors and corresponding mean running times on each day for animals 
with saline (r = 0.135), dizocilpine (r = 0.051), clozapine (r = 0.203) or dizo- 
cilpine plus clozapine injections (r = 0.17). 
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Discussion 
Systemic administration f the noncompetitive NMDA antagonist dizocilpine 
significantly impaired elayed alternation learning in rats on all days tested. 
Pretreatment with the atypical neuroleptic clozapine significantly improved the 
dizocilpine-induced impairment on four out of six days. Clozapine when given 
alone did not alter delayed alternation learning except of the first day. 
Furthermore animals with injections of dizocilpine, clozapine and clozapine 
plus dizocilpine showed ifferences in their respective locomotor activities: The 
mean running times from all days were significantly reduced in dizocilpine- 
treated animals and increased in clozapine-treated animals. Clozapine antag- 
onized reduced running times in dizocilpine-pretreated animals. No correlations 
were found between treatment-induced errors in delayed alternation learning 
and changes of running times. 
As expected izocilpine markedly impaired the acquisition of delayed al- 
ternation which replicates imilar findings in a previous tudy (Schmidt et al., 
1988). This result is also in accordance with studies showing that ketamine, 
another noncompetitive NMDA antagonist, produced a similar impairment in
the same task (Alessandri et al., 1989; Hauber and Schmidt, 1990). 
The observation that dizocilpine significantly decreased running times in 
the maze is also in line with studies howing a dizocilpine-induced increase of 
spontaneous locomotor activity (Tiedtke t al., 1990; Hoffman, 1992). Regard- 
ing the relationship between errors and corresponding running times, both 
measures seem to be independent regardless of the treatment used here: 
I) Dizocilpine-treated animals had the same running times in correct and 
incorrect choices. Although dizocilpine increased locomotor activity a com- 
mitted error seems not to be a direct consequence of the increased locomotor 
activity during the corresponding choice. Thus nonspecific motor effects af- 
fecting running time such as ataxia are not causative for the observed increase 
of errors and this means in turn that clozapine's antagonistic action on errors 
is not due to a reduction of these effects. 
II) neither in dizocilpine- nor in clozapine-, clozapine plus dizocilpine- or 
saline-treated animals a correlation of running times and errors was found. 
Therefore it is concluded that dizocitpine induced apsychomotor activation 
which is characterized by a increased locomotor activity and a cognitive im- 
pairment leading to an impaired elayed alternation learning and both processes 
seem to be independent. In line with this conclusion is the finding that ketamine 
selectively impaired acquisition of delayed alternation by naive animals, while 
retrieval of delayed alternation by ketamine-treated animals trained undrugged 
to a criterion before was intact. Thus the influence of ketamine-induced non- 
specific motor effects on impaired acquisition can be neglected, since retrieval 
remained intact in ketamine-treated animals (Hauber and Schmidt, 1989). 
To the authors knowledge this is the first study using simultaneous mea- 
surement of errors and running times in this maze task. Results show that this 
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could be a simple way to gain more information about drug-induced changes 
of locomotor behaviour and their possible effects on learning. 
Clozapine when given alone did not alter acquisition of delayed alternation, 
except of the first day on which a significant worsening was observed for 
unknown reasons. Thus a cognitive enhancing effect of clozapine possibly in- 
dicative for a glutamate-agonistic effect of clozapine was not detectable in this 
task. This may have among others task-related reasons ince clozapine mildly 
improved the finding of a hidden platform in the Morris water task in the same 
dose used here (Scheel-Kr/iger and Widy-Tyszkiewicz, 1990). 
Clozapine-pretreatment significantly improved izocilpine-induced delayed 
alternation impairment. In a pilot study this clozapine-dizocilpine antagonism 
in delayed alternation was also observed using the same dose of clozapine 
together with a lower dose (0.12 mg/kg) of dizocilpine (Hauber, 1993). As 
already discussed, clozapine's action seems not be due to a reduction of non- 
specific effects, but to a reduction of the dizocilpine-induced psychomotor 
activition which is characterized by a decreased locomotion and a decrease of 
errors. However, clozapine was effective not until the third day tested. The 
reason for this phenomenon is not clear. The results suggest that clozapine may 
act as a functional glutamate agonist via the NMDA receptor. This view is in 
accordance with findings on a clozapine-dizocilpine antagonism in studies with 
spontaneous behaviour and similarities between clozapine and NMDA in a 
drug discrimmination test (see Introduction). However, Katz and Schmaltz 
(1981) found that not only the NMDA antagonist amantadine but also the DA 
agonist apomorphine induced a spatial alternation impairment that is char- 
acterized by perseveration reflecting an abnormal attentional process. Since 
dizocilpine stimulates DA synthesis, release and metabolism (Bubser et al., 1992; 
Imperato, 1990; Svensson et al., 1992) one may argue that deficient learning of 
delayed alternation is DA-dependent and clozapine-induced improvement is
brought about by its DA receptor blocking properties (see Coward, 1992). 
However, the DA stimulating effects of dizocilpine in the dose used here are 
weak (Rao etal., 1990) and behavioural stimulation produced by dizocilpine 
is still present in monoamine-depleted mice pretreated with haloperidol as shown 
by Carlsson and Carlsson (1989). Besides haloperidol can lead even in low doses 
to a significant impairment of spatial earning in the Morris water task (Ploeger 
etal., 1992). In an 8-arm radial maze task, haloperidol exacerbated impaired 
learning in dizocilpine-treated animals (Bischoff et al., 1988). Thus the involve- 
ment of a DA-dependent-mechanism seems to be unlikely for the dizocilpine- 
clozapine antagonism in the task used here although in general dizocilpine- 
induced behavioural stimulation can be mediated through dopamine-dependent 
and dopamine-independent mechanisms (Carlsson and Carlsson, 1990). 
The integrity of the medial part of the striatum and of the prefrontal cortex 
is a prerequisite for intact acquisition of delayed alternation (Wikmark et al., 
1973; Fuster, 1981; Markowitsch and Pritzel, 1977; Pisa and Cyr, 1990). Both 
structures are anatomically inked by neurons of the prefrontal cortex projecting 
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to the medial striatum and using most probably glutamate as transmitter (Fon- 
num, 1984). Furthermore, both structures are part of a cortico-striato-thalamo- 
cortical functional oop suggested to mediate cognitive functions (Alexander 
etal., 1986). Blockade of NMDA receptors in the medial striatum by local 
infusion of the competitive NMDA antagonist AP-5 produced a similar im- 
pairment in the same task as used here (Hauber and Schmidt, 1989). These 
findings suggest hat NMDA receptors in the medial striatum are one site of 
action of systemically administered dizocilpine leading to an impaired acqui- 
sition of delayed alternation. If so clozapine may counteract dizocilpine-me- 
diated effects by a modulation of the activity of prefrontal glutamatergic neurons 
projecting to the medial striatum. This view is in line with the glutamate hy- 
pothesis of schizophrenia. 
In summary the present finding that clozapine improved izocilpine-induced 
impairment of delayed alternation learning suggests that this atypical neuro- 
leptic may act as a functional glutamate agonist via the NMDA receptor. It is 
speculated that this effect may be brought about by an action within the cognitive 
cortico-striato-cortical loop. 
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